Late breaking Clinical Trial News 2015



08.30-09.00 Registration and Coffee
09.00-9.10 Welcome and Introduction
Yves Geysels, President
Moderator morning session: Dr. Josse Thomas
09.10-9.40 Clinical Trials Regulation: Main Challenges and Changes
Greet Musch, FAGG
09.40-10.15 The Medical Device Regulations
Dario Pirovano, Regulatory Adviser, Eucomed
10.15-11.00 The Value of Integrity
Frank Wells
11.00-11.30 Coffee
11.30-11.55 Parkinson Research from a patient perspective
Dr Silvia Nezosi, UK
11.55-12.20 Quality and Informed Consent Procedures
Hilde Maes, Oncology Research Center, GZA
12.20-13.00 Threads and opportunities of Clinical Research in 2015
Dr. Bernard De Bruyne, MD, Cardiovascular Center OLVZ Aalst
13.00-14.00 Lunch
Moderator afternoon session: Dr. Robert Lins
14.00-14.25  Changing Role of CRA in Data Driven Trial Execution
Oliver Boden
14.25-14.50 Patient participation in clinical trial development
Elizabeth Vroom, NL
14.50-15.40 Panel discussion: How to adapt Clinical Trial Execution unique development needs in Biotech
Annegret Van der Aa, Clinical Operations, Galapagos
Ian Rentsch, Chair ACRP Deutschland e.V
15.40-16.05 Cathedral Challenges
What happens after what comes next?
Herman Konings, Trendwatcher
16.05-16.20 General Conclusion
16.20 Reception